ES2085657T3 - Un medicamento de accion retardada que contiene flurbiprofeno y su utilizacion. - Google Patents

Un medicamento de accion retardada que contiene flurbiprofeno y su utilizacion.

Info

Publication number
ES2085657T3
ES2085657T3 ES92924552T ES92924552T ES2085657T3 ES 2085657 T3 ES2085657 T3 ES 2085657T3 ES 92924552 T ES92924552 T ES 92924552T ES 92924552 T ES92924552 T ES 92924552T ES 2085657 T3 ES2085657 T3 ES 2085657T3
Authority
ES
Spain
Prior art keywords
flurbiprofen
flurbiprophen
medicine containing
delayed action
racemate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92924552T
Other languages
English (en)
Inventor
Jens-Christian Wunderlich
Otto Schuster
Helmut Lukas
Ursula Schick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfatec Pharma GmbH
Original Assignee
Alfatec Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfatec Pharma GmbH filed Critical Alfatec Pharma GmbH
Application granted granted Critical
Publication of ES2085657T3 publication Critical patent/ES2085657T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

UN MEDICAMENTO QUE CONTIENE UNA COMPOSICION DE RETARDO DE SUSTANCIA ACTIVA DE FLURBIPROFENO EN FORMA DE RACEMATO, DE UNA MEZCLA DE UN RACEMATO Y SUS ENANTIOMEROS, DE UN SEUDORRACEMATO (MEZCLAS DE PARTES IGUALES DE SMEZCLA DE PARTES DIFERENTES DE S MA EXISTENTE ENTRE S DE UN NANOSOL APLICABLE FARMACEUTICAMENTE A BASE DE GELATINA. ESTE MEDICAMENTO SATISFACE LOS REQUERIMIENTOS DE UNA TERAPIA EFICIENTE ANTIRREUMATICA Y/O ANALGESICA.
ES92924552T 1991-12-05 1992-12-04 Un medicamento de accion retardada que contiene flurbiprofeno y su utilizacion. Expired - Lifetime ES2085657T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4140183A DE4140183C2 (de) 1991-12-05 1991-12-05 Retardform für ein Flurbiprofen enthaltendes Arzneimittel

Publications (1)

Publication Number Publication Date
ES2085657T3 true ES2085657T3 (es) 1996-06-01

Family

ID=6446388

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92924552T Expired - Lifetime ES2085657T3 (es) 1991-12-05 1992-12-04 Un medicamento de accion retardada que contiene flurbiprofeno y su utilizacion.

Country Status (8)

Country Link
EP (1) EP0615447B1 (es)
AT (1) ATE134876T1 (es)
AU (1) AU3080792A (es)
DE (2) DE4140183C2 (es)
DK (1) DK0615447T3 (es)
ES (1) ES2085657T3 (es)
GR (1) GR3020144T3 (es)
WO (1) WO1993010771A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10047319A1 (de) 2000-09-25 2002-04-18 Paz Arzneimittelentwicklung Verwendung von R-Arylpropionsäuren zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen, welche durch die Hemmung der Aktivierung des nukleären Transkriptionsfaktors AP-1 therapeutisch beeinflußt werden können
DE102004041340A1 (de) * 2004-08-20 2006-02-23 Deutsche Gelatine-Fabriken Stoess Ag Nanopartikel und Verfahren zu deren Herstellung
CA2752849C (en) 2009-07-24 2014-07-08 Bernd G. Seigfried Liquid compositions capable of foaming and including active agents, and methods for making or developing same
TR201721036A2 (tr) * 2017-12-21 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Flurbi̇profeni̇n modi̇fi̇ye salimli formülasyonlari

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) * 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
DE3205504C2 (de) * 1982-02-16 1983-12-01 Dolorgiet Gmbh & Co Kg, 5300 Bonn Äußerlich anwendbares, Ibuprofen enthaltendes Arzneimittel
US4571333A (en) * 1983-06-14 1986-02-18 Syntex (U.S.A.) Inc. Controlled release naproxen and naproxen sodium tablets
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
GB8524421D0 (en) * 1985-10-03 1985-11-06 Boots Co Plc Therapeutic agents
JPS62126122A (ja) * 1985-11-27 1987-06-08 Showa Shinyaku Kk 表面コ−テイングされたイブプロフエン顆粒の製法
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
US4704436A (en) * 1986-05-02 1987-11-03 Barabas Eugene S Water soluble complex of a poly(vinylpyrrolidone) copolymer and α-methyl-(2-methylpropyl)benzene acetic acid
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
EP0267321B1 (de) * 1986-11-14 1990-02-28 MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG Ibuprofen enthaltendes Arzneimittel
NL194638C (nl) * 1986-12-19 2002-10-04 Novartis Ag Hydrosol die vaste deeltjes van een farmaceutisch actieve stof bevat en farmaceutisch preparaat dat deze hydrosol bevat.
FR2608988B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
CH673395A5 (es) * 1987-01-30 1990-03-15 Ciba Geigy Ag
CA1324083C (en) * 1987-03-09 1993-11-09 Tetsu Miyoshi Pharmaceutical preparations containing non-steroidal anti-inflammatory agents
US4806359A (en) * 1987-04-22 1989-02-21 Mcneilab, Inc. Iburprofen sustained release matrix and process
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
US4980375A (en) * 1987-07-10 1990-12-25 Sterling Drug Inc. Onset-hastened/enhanced antipyretic response
US4859704A (en) * 1987-10-15 1989-08-22 Oratech Pharmaceutical Development Corporation Water soluble ibuprofen compositions and methods of making them
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
US4868214A (en) * 1987-11-17 1989-09-19 Analgesic Associates Onset-hastened/enhanced analgesia
US4835188A (en) * 1987-12-08 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4996209A (en) * 1988-06-20 1991-02-26 Alcon Laboratories, Inc. Ophthalmic antiinflammatory compositions comprising S(+)-flurbiprofen
DE3824353A1 (de) * 1988-07-19 1990-01-25 Paz Arzneimittelentwicklung Verfahren zur trennung von gemischen enantiomerer arylpropionsaeuren
WO1991006295A1 (en) * 1989-11-06 1991-05-16 Sepracor, Inc. Analgesic composition containing optically pure s(+) flurbiprofen
DE3938227C1 (en) * 1989-11-17 1991-05-02 Dolorgiet Gmbh & Co Kg, 5205 St Augustin, De Oral antiinflammatory and analgetic pharmaceutical compsn. - comprises magnesium ibuprofen dissolved in mixt. of water, propane-1,2-diol and glycerol
DE4028906A1 (de) * 1990-09-12 1992-03-19 Paz Arzneimittelentwicklung Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen

Also Published As

Publication number Publication date
EP0615447B1 (de) 1996-03-06
DE4140183C2 (de) 1995-12-21
DE59205626D1 (de) 1996-04-11
GR3020144T3 (en) 1996-08-31
EP0615447A1 (de) 1994-09-21
DK0615447T3 (da) 1996-04-01
DE4140183A1 (de) 1993-06-17
ATE134876T1 (de) 1996-03-15
WO1993010771A1 (de) 1993-06-10
AU3080792A (en) 1993-06-28

Similar Documents

Publication Publication Date Title
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
WO1994027589A3 (en) Antidepressant dosage form
YU49026B (sh) UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE
ES2152662T3 (es) Aguja para inyeccion.
PT1035834E (pt) Forma de dosagem osmotica que compreende primeiro e segundo revestimentos
GR3034162T3 (en) Liposome-encapsulated taxol, its preparation and its use
ES2090712T3 (es) Medicamento agudo que contiene ibuprofeno y su uso.
MX9307644A (es) Medicamento que incluye 2-amino-6-n-propil-amino-4,5, 6, 7,-tetrahidrobenzotiazol con efecto antidepresivo.
EE03420B1 (et) Farmatseutiline kompositsioon maania ja bipolaarse häire raviks
ES2090703T3 (es) Medicamento agudo que contiene flurbiprofeno y su empleo.
AP1901A (en) Pharmaceutical composition for modified release insulin sensitiser.
MY111718A (en) Deuterated active substances in transdermal application
ES2085657T3 (es) Un medicamento de accion retardada que contiene flurbiprofeno y su utilizacion.
ES2082523T3 (es) Un medicamento de accion retardada que contiene ibuprofen y su empleo.
PT91584A (pt) Processo para a preparacao de uma composicao farmaceutica util para imunossupressao contendo um inibidor-activador de plasminogenio (pai-2)
KR850008664A (ko) 4-아미노-n-(1-페닐에틸)벤즈아미드의(s)-및(r)-에난티오머의 제조방법
CA2129527A1 (fr) Composition pharmaceutique utilisable comme analgesique contenant l'acide (benzoyl-3 phenyl)-2 propionique-(r)
ATE124627T1 (de) Diclofenac-natrium enthaltende pharmazeutische zusammensetzung zur topischen anwendung.
MX9302986A (es) Medicamento que contiene metrifonato y procedimiento para su preparacion
MX9400038A (es) Composiciones y metodos para proveer un efecto analgesico mejorado.
AR013538A1 (es) Nuevos mitogenos especificos de osteoblastos, metodos para prepararlos y drogas que contienen tales compuestos
PE20011042A1 (es) Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan
FR2613935B1 (fr) Association renfermant a titre de principes actifs, un analgesique central et la forskoline
JO1880B1 (en) Format 1 for multi-unit calibration discs

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 615447

Country of ref document: ES